To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open1,551.1
High1,567.5
Low1,529.1
Prev. Close1,541.5
Avg. Traded Price1,538.03
Volume2,24,736

MARKET DEPTH

info2
Total bid11.00
Total ask0.00
OrdersQtyBid
1111541.5
000
000
000
000
AskQtyOrders
000
000
000
000
000

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

1,529.1014 hours ago
1,567.5016 hours ago
arrow

LOWER/UPPER CIRCUITS

1,240.00
1,859.80
arrow
Inventurus Knowledge Solutions Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 45.48%, in the last year to ₹2,702.99 Cr. Its sector's average revenue growth for the last fiscal year was 16.1%.
noteAnnual Net Profit,rose 31.19% in the last year to ₹486.06 Cr. Its sector's average net profit growth for the last fiscal year was 91.1%.
notePrice to Earning Ratio,is 49.06, lower than its sector PE ratio of 71.31.
View more

About Inventurus Knowledge Solutions Limited (IKS Health)

 

Inventurus Knowledge Solutions Limited (IKS Health) is a leading technology-enabled healthcare solutions provider with a unified Care Enablement platform that supports healthcare enterprises across outpatient and inpatient settings. Founded in 2006, the company partners with over 700 clients—among them large hospitals, health systems and specialty groups—and serves around 18% of all US physicians. Its solutions blend technology with deep human expertise to reduce administrative burden, enhance outcomes and strengthen financial sustainability for provider organisations . Headquartered in Mumbai, IKS operates across the US and India, with a limited presence in Canada and Australia, and employs over 12,000 professionals, including 450+ technologists and 2,200+ clinical staff.

 

The company’s integrated offerings span Revenue Optimisation Services, Clinical Support Solutions and Value-Based Care enablement, helping providers transform revenue cycle management, improve clinical documentation and coding, coordinate care across the continuum and thrive under outcomes-based reimbursement models.

 

As on March 31, 2025, IKS had 7 subsidiaries, reflecting a growing global footprint and integrated delivery model. The consolidated financial statements include details of subsidiary performance, while the company maintains a policy for determining material subsidiaries on its website . Key milestones include the acquisition of Aquity Solutions on October 27, 2023, which strengthened its capabilities and scale, and the company’s transition to a publicly listed entity in India in December 2024 .

 

Inventurus Knowledge Solutions Limited’s Business Segments

 

  • Operating segment: Care Enablement platform (single reportable segment) – 100% of revenue (as per Ind AS 108).
  • Geography: International (USA) – 100% of revenue; Domestic (India) – 0%.

 

Inventurus Knowledge Solutions Limited Key Management

  • Berjis Desai – Chairman & Non-Executive Director
  • Sachin K. Gupta – Founder & Global CEO
  • Nithya Balasubramanian – Chief Financial Officer
  • Sameer Chavan – Company Secretary

 

Latest Updates on Inventurus Knowledge Solutions Limited (IKS Health)

 

  • Public listing: Equity shares listed on BSE and NSE with effect from December 19, 2024, marking IKS’s first year as a publicly listed company.
  • IPO reception: The initial public offering was oversubscribed more than 52 times, underscoring strong investor interest in the company’s model and strategy.
  • Board composition: Appointment of Ms. Theresa Anne Stone as an Independent Director on November 20, 2024, strengthening governance and clinical oversight at the board level.
  • Secretarial audit updates: The Board approved the appointment of M/s Manish Ghia & Associates as Secretarial Auditors for five consecutive years from FY 2025-26 to FY 2029-30, subject to shareholders’ approval; the FY 2024-25 secretarial audit carried no adverse remarks.
personal

Grow your wealth with more research recommendations

+91

Frequently Asked Questions

IKS provides a Care Enablement platform for US healthcare providers, offering Revenue Optimisation Services, Clinical Support Solutions and Value-Based Care capabilities. Its solutions combine technology and specialised teams to reduce administrative burden and improve outcomes.

The company is headquartered in Mumbai and operates across the US and India, with limited presence in Canada and Australia. It partners with over 700 clients and serves around 18% of US physicians.

As on March 31, 2025, the company had 7 subsidiaries. The consolidated financials include a statement of salient features for these entities.